V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220017718 | 220008662 | null | 94.25 | Curative (C) | 2017-11-04 | 2017-11-05 | RUXOLITINIB | 02 | N | 220032665 | RUXOLITINIB |
| 220017719 | 220008663 | 1.76 | 87.2 | Curative (C) | 2016-05-19 | 2016-06-13 | Alemtuzumab cond (RI ALLO CAMP100) | 02 | N | 220032666 | ALEMTUZUMAB |
| 220017721 | 220008666 | 1.58 | 123 | Palliative (P) | 2014-02-22 | 2014-03-01 | Carboplatin + Etoposide iv&po | 02 | N | 220032681 | CARBOPLATIN + ETOPOSIDE |
| 220017722 | 220008670 | 1.76 | 78.3 | Palliative (P) | null | 2018-05-18 | GEMTUZUMAB OZOGAMICIN | N | null | 220032682 | OXALIPLATIN + MDG |
| 220017723 | 220008672 | 1.65 | 64.8 | Palliative (P) | 2016-08-31 | 2016-09-02 | Irinotecan + Modified De Gramont | N | N | 220032692 | FLUDARABINE + MELPHALAN |
| 220017724 | 220008674 | 1.79 | 64.95 | Adjuvant (A) | 2013-05-14 | 2013-05-14 | PACLITAXEL | Y | N | 220032694 | PACLITAXEL |
| 220017725 | 220008676 | 1.84 | 89 | Palliative (P) | 2013-12-14 | 2014-02-06 | Irinotecan + Modified De Gramont | 02 | N | 220032695 | CISPLATIN + GEMCITABINE |
| 220017727 | 220008683 | 1.66 | 88.5 | Curative (C) | 2015-04-05 | 2015-08-10 | Arsenic trioxide + Tretinoin | 01 | N | 220032713 | ARSENIC TRIOXIDE + TRETINOIN |
| 220017728 | 220008685 | 1.8 | 78.1 | Curative (C) | 2014-06-07 | 2014-06-10 | IDARUBICIN | null | null | 220032717 | IDARUBICIN |
| 220017729 | 220008689 | 1.7 | null | Curative (C) | 2017-09-03 | 2017-09-12 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220032724 | METHOTREXATE |
| 220017730 | 220008691 | 0 | 49.499 | Curative (C) | 2013-09-06 | 2013-09-06 | Clofarabine + Cytarabine | N | N | 220032727 | GEMCARBO |
| 220017731 | 220008693 | 1.53 | null | Adjuvant (A) | 2018-01-11 | 2018-01-29 | FLUOROURACIL + OXALIPLATIN | N | N | 220032728 | PONATINIB |
| 220017732 | 220008696 | 1.85 | 106 | Palliative (P) | 2016-09-30 | 2016-10-17 | FLUOROURACIL + IRINOTECAN | N | N | 220032730 | UKALL2014 |
| 220017733 | 220008699 | 1.59 | 89.4 | Curative (C) | 2017-04-08 | 2017-04-20 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220032740 | ALEMTUZUMAB |
| 220017734 | 220008700 | 1.74 | 47.75 | Disease modification (D) | 2017-02-13 | 2017-04-16 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220032742 | UKALL2014 |
| 220017735 | 220008701 | 1.53 | 58.25 | Curative (C) | 2014-04-06 | 2014-04-07 | Mitoxantrone | N | N | 220032750 | MITOXANTRONE |
| 220017736 | 220008703 | 1.63 | 73.3 | Palliative (P) | 2015-01-18 | 2015-01-19 | CARBOPLATIN + GEMCITABINE | N | N | 220032770 | METHOTREXATE |
| 220017737 | 220014683 | 1.66 | 68.6 | Curative (C) | 2017-01-03 | 2017-01-13 | UKALL14- Intens/CNS Proph | N | N | 220032771 | METHOTREXATE |
| 220017738 | 220008707 | 1.79 | 80.6 | Adjuvant (A) | 2014-11-23 | 2014-11-28 | PONATINIB | 2 | N | 220032778 | CISPLATIN + GEMCITABINE |
| 220017739 | 220008711 | 1.87 | 59.4 | Curative (C) | null | 2014-12-22 | IDARUBICIN | null | null | 220032781 | IDARUBICIN |
| 220017740 | 220008711 | 1.57 | 68.8 | null | 2016-07-07 | 2016-07-07 | Oxaliplatin + Modified de Gramont | N | N | 220032781 | ECX |
| 220017741 | 220008715 | 1.77 | null | Disease modification (D) | null | 2013-04-09 | IDARUBICIN | null | null | 220032789 | IDARUBICIN |
| 220017742 | 220008717 | 1.68 | 70 | Palliative (P) | null | 2013-09-16 | Mitox + Tretinoin Spanish Course 3 | 2 | N | 220032790 | MITOXANTRONE |
| 220017743 | 220008718 | 1.73 | 98.5 | Curative (C) | 2015-09-06 | 2015-09-06 | IDARUBICIN | N | null | 220032794 | IDARUBICIN |
| 220017746 | 220022106 | 1.8 | 64.8 | Curative (C) | 2016-03-28 | 2017-02-17 | CARBOPLATIN + ETOPOSIDE | N | N | 220032803 | CARBOPLATIN + ETOPOSIDE |
| 220017747 | 220008722 | null | 61 | Curative (C) | 2017-07-26 | 2017-07-26 | PONATINIB | N | N | 220032807 | FLUDARABINE + MELPHALAN |
| 220017748 | 220008724 | 2 | 58.6 | Adjuvant (A) | 2013-12-02 | 2013-12-06 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220032836 | METHOTREXATE |
| 220017749 | 220008725 | null | 88 | Curative (C) | 2013-02-28 | 2013-02-28 | Carboplatin + Etoposide iv&po | null | null | 220032838 | CARBOPLATIN + ETOPOSIDE |
| 220017750 | 220008727 | 1.61 | 94.7 | Curative (C) | 2013-07-01 | 2013-07-13 | Carboplatin + Paclitaxel (3 weekly) | N | null | 220032855 | CARBOPLATIN + PACLITAXEL |
| 220017751 | 220008729 | null | 58.3 | Curative (C) | 2015-08-15 | 2015-12-02 | CARBOPLATIN + GEMCITABINE | 2 | N | 220032856 | OXALIPLATIN + MDG |
| 220017752 | 220008733 | 1.69 | 83.7 | Curative (C) | 2017-07-21 | 2017-07-21 | Oxaliplatin + Modified de Gramont | 2 | N | 220032862 | FLUDARABINE + MELPHALAN |
| 220017753 | 220008734 | 1.72 | 55 | Disease modification (D) | 2016-10-30 | 2017-02-26 | Oxaliplatin + Modified de Gramont | N | N | 220032862 | GEMCARBO |
| 220017754 | 220008738 | 1.73 | null | null | null | 2015-11-23 | Carboplatin + Paclitaxel (weekly) | N | null | 220032865 | CARBOPLATIN + PACLITAXEL |
| 220017755 | 220008739 | null | 88.5 | Adjuvant (A) | 2015-12-20 | 2015-12-21 | Docetaxel 75mg/m2 (21 day) | Y | null | 220032870 | ECX |
| 220017756 | 220008740 | 1.73 | 89.4 | Curative (C) | 2017-02-15 | 2017-05-30 | Mitox + Tretinoin Spanish Course 3 | N | N | 220032871 | MITOXANTRONE |
| 220017757 | 220008741 | 1.77 | 25.35 | Curative (C) | null | 2018-03-27 | Docetaxel 75mg/m2 (21 day) | N | N | 220032872 | IRINOTECAN + MDG |
| 220017758 | 220014700 | 1.9 | 74.75 | Curative (C) | 2015-03-27 | 2015-03-28 | UKALL14- Maintenance | N | N | 220032874 | OXALIPLATIN + MDG |
| 220017759 | 220008745 | null | 56.6 | Curative (C) | 2018-03-05 | 2018-04-01 | UKALL14- Ph 2 Induction | 01 | N | 220032880 | FLUDARABINE + MELPHALAN |
| 220017760 | 220014701 | 1.74 | 56.6 | Curative (C) | 2015-05-23 | 2015-05-24 | Mitoxantrone | N | N | 220032881 | MITOXANTRONE |
| 220017761 | 220008748 | null | 66.8 | Curative (C) | 2013-02-05 | 2013-02-09 | Cytarabine intrathecal | 2 | N | 220032887 | CYTARABINE INTRATHECAL |
| 220017762 | 220008749 | 1.68 | 89 | Curative (C) | 2017-09-09 | 2017-09-09 | METHOTREXATE | N | N | 220032899 | PONATINIB |
| 220017763 | 220008753 | null | 77.1 | null | 2018-01-06 | 2018-01-22 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | null | null | 220032908 | PONATINIB |
| 220017764 | 220008756 | 1.59 | 77.9 | Curative (C) | 2015-08-15 | 2015-09-21 | Clofarabine + Cytarabine | N | N | 220032911 | OXALIPLATIN + MDG |
| 220017765 | 220008761 | 1.73 | 99.4 | Curative (C) | 2014-08-18 | 2014-11-14 | Alemtuzumab cond (RI ALLO CAMP100) | 2 | N | 220032919 | ALEMTUZUMAB |
| 220017766 | 220008763 | 1.68 | null | Curative (C) | 2015-08-03 | 2015-08-03 | ECX | Y | N | 220032920 | CISPLATIN + GEMCITABINE |
| 220017767 | 220008765 | 1.56 | 62.3 | Disease modification (D) | 2017-08-23 | 2017-09-11 | ECX | N | null | 220032932 | CLOFARABINE + CYTARABINE |
| 220017768 | 220014708 | null | 74.3 | Curative (C) | 2018-04-18 | 2018-04-25 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | Y | null | 220032935 | METHOTREXATE |
| 220017769 | 220008767 | 1.66 | 53 | Curative (C) | 2016-02-20 | 2016-02-20 | FLUDARABINE + MELPHALAN | 02 | N | 220032937 | METHOTREXATE |
| 220017770 | 220020972 | 1.67 | 89.4 | Curative (C) | 2016-03-23 | 2016-03-27 | GEMTUZUMAB OZOGAMICIN | N | null | 220032949 | IRINOTECAN + MDG |
| 220017771 | 220014710 | null | 73.4 | Curative (C) | 2016-08-11 | 2016-09-09 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 220032973 | PACLITAXEL |